1[1]Gray PW,Goeddel DV. Structure of the human immune interferon gene[J]. Nature,1982;298(5877):859- 863.
2[2]Sporn MB,Robert AB. Peptide growth factors and their receptors, Ⅱ [M]. Berlin:Springer-Verlag,1990:1- 38.
3[3]Gaafar A, Kharazmi A, Ismail A, et al. Dichotomy of the T cell response to Leishmania antigens in patients suffering from cutaneous leishmaniasis; absence or scarcity of Th1 activity is associated with severe infections[J].Clin Exp Immunol, 1995;100(2):239- 245.
4[4]Belosevic M, Finbloom DS, Van Der Meide PH, et al. Administration of monoclonal anti-IFN-gamma antibodies in vivo abrogates natural resistance of C3H/HeN mice to infection with Leishmania major[J]. J Immunol,1989;143(1):266- 274.
5[5]Romagnani S. Role for CD30 antigen in human T helper 2-type responses[J]. Ciba Found Symp, 1995;195:55- 62.
6[6]Follador I, Araujo C, Bacellar O, et al. Epidemiologic and immunologic findings for the subclinical form of Leishmania braziliensis infection[J]. Clin Infect Dis,2002;34(11):E54- 8.
7[7]Gazzinelli RT, Oswald IP, James SL, et al. IL-10 inhibits parasite killing and nitrogen oxide production by IFN-gamma-activated macrophages[J]. J Immunol,1992;148(6):1792- 1796.
8[8]Johnson LL, Sayles PC. Strong cytolytic activity of natural killer cells is neither necessary nor sufficient for preimmune resistance to Toxoplasma gondii infection[J]. Natural Immun, 1995;14(4):209- 215.
9[9]Hayashi S,Chan C,R Gazzinelli R. Contribution of nitruc oxide to the host parasite equilibrium in toxoplasmosis[J]. J Immunol,1996;156:1476- 1481.
10[10]Nagineni CN, Pardhasaradhi K, Martins MC, et al. Mechanisms of interferon-induced inhibition of Toxoplasma gondii replication in human retinal pigment epithelial cells[J]. Infect Immun, 1996;64(10):4188- 4196.
